Benzinga Rankings give you vital metrics on any stock – anytime.
Explore Cyclacel Pharmaceuticals stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for CYCC.
You can purchase shares of Cyclacel Pharmaceuticals (NASDAQ:CYCC) through any online brokerage.
Other companies in Cyclacel Pharmaceuticals’s space includes: Kezar Life Sciences (NASDAQ:KZR), Estrella Immunopharma (NASDAQ:ESLA), Burning Rock Biotech (NASDAQ:BNR), Coeptis Therapeutics (NASDAQ:COEP) and Barinthus Biotherapeutics (NASDAQ:BRNS).
Cyclacel Pharmaceuticals has a consensus price target of $9.50.
The stock price for Cyclacel Pharmaceuticals (NASDAQ: CYCC) is $2.26 last updated May 16, 2025 at 9:10 AM EDT.
There are no upcoming dividends for Cyclacel Pharmaceuticals.
Cyclacel Pharmaceuticals’s Q2 earnings are confirmed for Wednesday, August 13, 2025.
There is no upcoming split for Cyclacel Pharmaceuticals.
Cyclacel Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.